Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Vyas

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Cancer Chemotherapy and Pharmacology|August 10, 2014
Anticancer activity of VDR-coregulator inhibitor PS121912Preetpal S Sidhu, Kelly Teske, Belaynesh Feleke, et al.
Plos Pathogens|May 30, 2025
Extracellular vesicles from diverse fungal pathogens induce species-specific and endocytosis-dependent immunomodulationGeneva N Kwaku, Kirstine Nolling Jensen, Patricia Simaku, et al.
Journal of Dairy Science|December 27, 2021
Lactational performance of dairy cows in response to supplementing N-acetyl-l-methionine as source of rumen-protected methionineF X Amaro, D Kim, R Restelatto, et al.
Blood Neoplasia|August 12, 2025
Real-world performance of the CALGB 10403 regimen in young adults in the United StatesBrandon DaSilva, Alicia Darwin, Amy Zhang, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Model studies on a synthetically facile series of N-substituted phenyl-N'-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT(2C/2B) receptor antagonistsS M Bromidge, S Dabbs, D T Davies, et al.
JCI Insight|September 9, 2025
Virologic characteristics of SARS-CoV-2 infection across evolving Omicron subvariantsJulie Boucau, Owen T Glover, Caitlin Marino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2022
Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19)Julie Boucau, Rockib Uddin, Caitlin Marino, et al.
Annals of Internal Medicine|November 13, 2023
SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy : An Observational StudyGregory E Edelstein, Julie Boucau, Rockib Uddin, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2023
SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapyGregory E Edelstein, Julie Boucau, Rockib Uddin, et al.
Journal of Dairy Science|August 29, 2023
Effects of direct-fed microbial supplementation on performance and immune parameters of lactating dairy cowsA O Oyebade, S Lee, H Sultana, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Cancer Chemotherapy and Pharmacology|August 10, 2014
Anticancer activity of VDR-coregulator inhibitor PS121912Preetpal S Sidhu, Kelly Teske, Belaynesh Feleke, et al.
Plos Pathogens|May 30, 2025
Extracellular vesicles from diverse fungal pathogens induce species-specific and endocytosis-dependent immunomodulationGeneva N Kwaku, Kirstine Nolling Jensen, Patricia Simaku, et al.
Journal of Dairy Science|December 27, 2021
Lactational performance of dairy cows in response to supplementing N-acetyl-l-methionine as source of rumen-protected methionineF X Amaro, D Kim, R Restelatto, et al.
Blood Neoplasia|August 12, 2025
Real-world performance of the CALGB 10403 regimen in young adults in the United StatesBrandon DaSilva, Alicia Darwin, Amy Zhang, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Model studies on a synthetically facile series of N-substituted phenyl-N'-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT(2C/2B) receptor antagonistsS M Bromidge, S Dabbs, D T Davies, et al.
JCI Insight|September 9, 2025
Virologic characteristics of SARS-CoV-2 infection across evolving Omicron subvariantsJulie Boucau, Owen T Glover, Caitlin Marino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2022
Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19)Julie Boucau, Rockib Uddin, Caitlin Marino, et al.
Annals of Internal Medicine|November 13, 2023
SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy : An Observational StudyGregory E Edelstein, Julie Boucau, Rockib Uddin, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2023
SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapyGregory E Edelstein, Julie Boucau, Rockib Uddin, et al.
Journal of Dairy Science|August 29, 2023
Effects of direct-fed microbial supplementation on performance and immune parameters of lactating dairy cowsA O Oyebade, S Lee, H Sultana, et al.
Pageof 12